Literature DB >> 9187628

Folate transport proteins mediate the bidirectional transport of 5-methyltetrahydrofolate in cultured human proximal tubule cells.

K M Morshed1, D M Ross, K E McMartin.   

Abstract

Although reabsorption across the apical (AP) membrane of the renal proximal tubule cell plays a vital role in the conservation of plasma 5-methyltetrahydrofolate, basolateral (BL) membrane-directed secretory pathways may also be important in regulating the urinary excretion of folate. Folate transport proteins, folate receptor and the reduced folate carrier have been implicated in the renal conservation of folate across the AP membrane, but their role in BL membrane-directed folate transport has not been studied. 5-Methyltetrahydrofolate transport across the AP and BL membranes of human proximal tubule cells was studied in cells grown on membrane inserts to allow optimum differentiation of AP and BL domains. Colchicine, an inhibitor of vesicular-mediated endocytosis, inhibited AP binding and AP-directed transport without affecting BL transport. Probenecid, an inhibitor of anion exchange, did not affect binding, but inhibited both AP and BL-directed transport with a greater effect on BL transport. Folic acid abolished AP binding of 5-methyltetrahydrofolate, but diminished AP-mediated transport by only 50%. These data suggest that both the folate receptor and the reduced folate carrier participate in AP uptake of folates by human kidney cells, but that BL-mediated uptake occurs primarily by the reduced folate carrier. Folate transport from the secretory direction occurred as readily as that from the reabsorptive direction, indicating that altered secretion could mediate excess urinary folate excretion.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9187628     DOI: 10.1093/jn/127.6.1137

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  7 in total

1.  The human reduced folate carrier gene is ubiquitously and differentially expressed in normal human tissues: identification of seven non-coding exons and characterization of a novel promoter.

Authors:  Johnathan R Whetstine; Robin M Flatley; Larry H Matherly
Journal:  Biochem J       Date:  2002-11-01       Impact factor: 3.857

2.  Preclinical evaluation of novel organometallic 99mTc-folate and 99mTc-pteroate radiotracers for folate receptor-positive tumour targeting.

Authors:  Cristina Müller; Alexander Hohn; P August Schubiger; Roger Schibli
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-06-09       Impact factor: 9.236

3.  Polarized expression of members of the solute carrier SLC19A gene family of water-soluble multivitamin transporters: implications for physiological function.

Authors:  Michael J Boulware; Veedamali S Subramanian; Hamid M Said; Jonathan S Marchant
Journal:  Biochem J       Date:  2003-11-15       Impact factor: 3.857

Review 4.  Assessment of the role of renal organic anion transporters in drug-induced nephrotoxicity.

Authors:  Yohannes Hagos; Natascha A Wolff
Journal:  Toxins (Basel)       Date:  2010-08-09       Impact factor: 4.546

5.  Rigorous optimization and validation of potent RNA CAR T cell therapy for the treatment of common epithelial cancers expressing folate receptor.

Authors:  Keith Schutsky; D Gang Song; Rachel Lynn; Jenessa B Smith; Mathilde Poussin; Mariangela Figini; Yangbing Zhao; Daniel J Powell
Journal:  Oncotarget       Date:  2015-10-06

6.  Regulation of CAR T cell-mediated cytokine release syndrome-like toxicity using low molecular weight adapters.

Authors:  Yong Gu Lee; Haiyan Chu; Yingjuan Lu; Christopher P Leamon; Madduri Srinivasarao; Karson S Putt; Philip S Low
Journal:  Nat Commun       Date:  2019-06-18       Impact factor: 14.919

Review 7.  Renal Reabsorption of Folates: Pharmacological and Toxicological Snapshots.

Authors:  Sophia L Samodelov; Zhibo Gai; Gerd A Kullak-Ublick; Michele Visentin
Journal:  Nutrients       Date:  2019-10-02       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.